Matt Hewitt
Stock Analyst at Craig-Hallum
(2.69)
# 2,150
Out of 5,076 analysts
40
Total ratings
54.05%
Success rate
3.42%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLP Simulations Plus | Maintains: Buy | $45 → $36 | $17.11 | +110.40% | 8 | Jun 13, 2025 | |
| CSBR Champions Oncology | Maintains: Buy | $8 → $12 | $6.00 | +100.00% | 4 | Mar 12, 2025 | |
| CLOV Clover Health Investments | Initiates: Buy | $6 | $2.50 | +140.00% | 1 | Dec 17, 2024 | |
| BLFS BioLife Solutions | Maintains: Buy | $30 → $32 | $25.41 | +25.93% | 4 | Nov 13, 2024 | |
| OMCL Omnicell | Maintains: Buy | $45 → $64 | $36.12 | +77.19% | 6 | Oct 31, 2024 | |
| NOTV Inotiv | Maintains: Buy | $25 → $10 | $0.88 | +1,034.82% | 3 | May 16, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $35 → $30 | $17.04 | +76.06% | 3 | May 2, 2024 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $1.63 | +329.45% | 1 | Nov 29, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $166.35 | +20.23% | 3 | Aug 3, 2023 | |
| OABI OmniAb | Initiates: Buy | $10 | $1.74 | +474.71% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $67 → $30 | $7.44 | +303.23% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $400 | $0.45 | +88,317.33% | 1 | Jan 4, 2022 |
Simulations Plus
Jun 13, 2025
Maintains: Buy
Price Target: $45 → $36
Current: $17.11
Upside: +110.40%
Champions Oncology
Mar 12, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $6.00
Upside: +100.00%
Clover Health Investments
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $2.50
Upside: +140.00%
BioLife Solutions
Nov 13, 2024
Maintains: Buy
Price Target: $30 → $32
Current: $25.41
Upside: +25.93%
Omnicell
Oct 31, 2024
Maintains: Buy
Price Target: $45 → $64
Current: $36.12
Upside: +77.19%
Inotiv
May 16, 2024
Maintains: Buy
Price Target: $25 → $10
Current: $0.88
Upside: +1,034.82%
Schrödinger
May 2, 2024
Maintains: Buy
Price Target: $35 → $30
Current: $17.04
Upside: +76.06%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $1.63
Upside: +329.45%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $166.35
Upside: +20.23%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $1.74
Upside: +474.71%
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $7.44
Upside: +303.23%
Jan 4, 2022
Initiates: Buy
Price Target: $400
Current: $0.45
Upside: +88,317.33%